Status:
COMPLETED
Refractory Chronic Cluster Headache: Exploring the Potential of Repetitive Transcranial Magnetic Stimulation
Lead Sponsor:
Hospital Universitario La Paz
Conditions:
Refractory Chronic Cluster Headache
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if drug ABC works to treat severe asthma in adults. It will also learn about the safety of drug ABC. The main questions it aims to answer are: Does Transcr...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Diagnosed with Chronic Cluster Headache (CCH) based on the International Classification of Headache Disorders 3rd Edition
- Diagnosed with refractory CCH based on the European Headache Federation criteria of 2014.
Exclusion
- History of epilepsy.
- Concomitant diagnosis of any other headache (if the patient was unable to differentiate between them).
- Carriers of any electronic device, or any additional contraindication for Transcranial Magnetic Stimulation, such as pregnancy.
Key Trial Info
Start Date :
December 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2024
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT06917144
Start Date
December 21 2023
End Date
May 31 2024
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario La Paz
Madrid, Madrid, Spain